Nu Skin Enterprises (NUS) Tops Q4 EPS by 16c, Offers Guidance
Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.38, $0.16 better than the analyst estimate of $0.22. Revenue for the quarter came in at $445.6 million versus the consensus estimate of $433.83 million.
GUIDANCE:
Nu Skin Enterprises sees Q1 2025 revenue of $345-365 million, versus the consensus of $404 million.
Q1 2025 Revenue | $345 to $365 million; (17)% to (13)% |
Q1 2025 EPS | $2.65 to $2.75 or $0.10 to $0.20 excluding the gain from the Mavely transaction |
2025 Revenue | $1.48 to $1.62 billion; (15)% to (6)% or (11)% to (3)% excluding Mavely revenue in 2024 |
2025 EPS | $3.45 to $3.85 or $0.90 to $1.30 excluding the gain from the Mavely transaction |
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.